Effects of angiogenesis inhibitor TNP-470 on the development of uterine adenomyosis in mice

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (33)

• Changes in Uterine Microvessels as a Possible Pathogenic Factor in the Development of Adenomyosis Induced by Pituitary Grafting in Mice. via openalex
• Disturbed Cell Arrangement, Increased Cell Membrane Permeability and Apoptotic Cell Death Occur in Adenomyotic Uterine Tissues in Mice via openalex
• Ectopic Pituitary Grafts in Mice: Hormone Levels, Effects on Fertility, and the Development of Adenomyosis Uteri, Prolactinomas, and Mammary Carcinomas* via openalex
• Effects of mifepristone (RU486) treatment on the development of uterine adenomyosis induced by pituitary grafting in mice via openalex
• Long-Term Responses of the Mouse Uterus to Neonatal Diethylstilbestrol Treatment and to Later Sex Hormone Exposure<xref ref-type="fn" rid="FN2">2</xref> via openalex
• Mechanisms of Development of Prolactin-Induced Adenomyosis in Mice via openalex
• Morphometric evaluation of stromal vascularization in the endometrium in adenomyosis via openalex
• Prolactin and Uterine Adenomyose in Mice via openalex
• The induction of adenomyosis in mice by intrauterine pituitary isografts via openalex
• W2011197306 via openalex
• W2019850232 via openalex
• W2041769554 via openalex
• W2048930729 via openalex
• W2064204050 via openalex
• W2086157929 via openalex
• W2088254867 via openalex
• W2112942470 via openalex
• W2150816401 via openalex
• W2161295454 via openalex
• W2167541685 via openalex
• W2261190893 via openalex
• W6634417623 via openalex
• W6635517444 via openalex
• W1517900928 via openalex
• W6693079684 via openalex
• W1574165892 via openalex
• W1590774636 via openalex
• W1950574246 via openalex
• W1967781859 via openalex
• W1972273438 via openalex
• W1978139448 via openalex
• W1990138449 via openalex
• W2010435021 via openalex

Cited by (12)

• Immunometabolic profiling of cervicovaginal lavages identifies key signatures associated with adenomyosis 2022
• Increased Angiogenesis and Lymphangiogenesis in Adenomyosis Visualized by Multiplex Immunohistochemistry 2022
• Animal Models of Adenomyosis 2020
• Benign Uterine Diseases 2019
• Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review 2019
• Improving the Preclinical Mouse Efficacy Studies of Adenomyosis 2015
• Constitutive and tumor necrosis factor-α-induced activation of nuclear factor-κB in adenomyosis and its inhibition by andrographolide 2013
• Literature Review on Biological Effects of against Gynaecological Diseases 2013
• Methodological Issues in Preclinical Mouse Efficacy Studies of Adenomyosis 2012
• Increased immunoreactivity to SLIT/ROBO1 and its correlation with severity of dysmenorrhea in adenomyosis 2010
• Expression of Vascular Endothelial Growth Factor (VEGF), Hypoxia Inducible Factor-1α (HIF-1α), and Microvessel Density in Endometrial Tissue in Women With Adenomyosis 2009
• Evaluation of the efficacy of a danazol-loaded intrauterine contraceptive device on adenomyosis in an ICR mouse model 2008

Source provenance

europepmc

last seen: 2026-06-12T06:13:51.797165+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-13T22:12:44.121522+00:00